Three-dimensional wet-spun microfibrous meshes of a star poly(∈-caprolactone) were developed as potential scaffolds endowed with antimicrobial activity. The in vitro release kinetics of the meshes, under physiological conditions, was initially fast and then a sustained release for more than one month was observed. Cell cultures of a murine pre-osteoblast cell line showed good cell viability and adhesion on the wet-spun star poly(∈-caprolactone) fiber scaffolds. These promising results indicate a potential application of the developed meshes as engineered bone scaffolds with antimicrobial activity.
Stock UA and Vacanti JPTissue engineering: Current state and prospects. Annu Rev Med2001; 52: 443-451.
2.
Puppi D., Chiellini F., Piras AM and Chiellini E.Polymeric materials for bone and cartilage repair. Prog Polym Sci2010; 35: 403-440.
3.
Gomes ME, Sikavitsas VI, Behravesh E., Reis RL and Mikos AGEffect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds . J Biomed Mater Res A67: 87-95.
4.
Tuzlakoglu K. , Alves CM, Mano JF and Reis RLProduction and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. Macromol Biosci2004; 4: 811-819.
5.
Toncheva A., Spasova M., Paneva D., Manolova N. and Rashkov I.Drug-loaded electrospun polylactide bundles. J Bioact Compat Polym2011; 26: 161-172.
6.
Puppi D., Piras AM, Detta N., Dinucci D. and Chiellini F.Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid. Acta Biomater2010 ; 6: 1258-1268.
7.
Puppi D., Piras AM, Detta N., Ylikauppila H., Nikkola L., Ashammakhi N., et al. Poly(vinyl alcohol)-based electrospun meshes as potential candidate scaffolds in regenerative medicine. J Bioact Compat Polym2011; 26: 20-34.
8.
Guarino V., Alvarez-Perez M., Cirillo V. and Ambrosio L.hMSC interaction with PCL and PCL/gelatin platforms: A comparative study on films and electrospun membranes. J Bioact Compat Pol2011; 26: 144-160.
9.
Maniglio D., Bonani W., Bortoluzzi G., Servoli E., Motta A. and Migliaresi C.Electrodeposition of silk fibroin on metal substrates. J Bioact Compat Polym2010; 25: 441-454.
10.
Leong MF, Chan WY, Chian KS, Rasheed MZ and Anderson JMFabrication and in vitro and in vivo cell infiltration study of a bilayered cryogenic electrospun poly(D,L-lactide) scaffold. J Biomed Mater Res A2010; 94: 1141-1149.
11.
Heydarkhan-Hagvall S., Schenke-Layland K., Dhanasopon AP, Rofail F., Smith H., Wu BM, et al. Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering . Biomaterials2008; 29: 2907-2914.
12.
Zhang Y., Ouyang H., Lim CT, Ramakrishna S. and Huang ZMElectrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds . J Biomed Mater Res B Appl Boimater2005; 72: 156-165.
13.
Oliveira JT , Crawford AT, Mundy JM, Moreira AR, Gomes ME, Hatton PV, et al. A cartilage tissue engineering approach combining starch-polycaprolactone fiber mesh scaffolds with bovine articular chondrocytes. J Mater Sci Mater Med2007 ; 18: 295-302.
14.
Tuzlakoglu K. , Pashkuleva I., Rodrigues MT, Gomes ME, van Lenthe GH, Müller R., et al. A new route to produce starch-based fiber mesh scaffolds by wet spinning and subsequent surface modification as a way to improve cell attachment and proliferation . J Biomed Mater Res A2010; 92: 369-377.
15.
Gomes ME, Bossano CM, Johnston CM, Reis RL and Mikos AG In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor . Tissue Eng2006; 12: 177-188.
16.
Tuzlakoglu K. and Reis R.Chitosan-based scaffolds in orthopaedic applications. In: Reis RL, Neves NM , Mano JF, Gomes ME, Marques AP and Azevedo HS. (eds). Natural-based polymers for biomedical applications. Cambridge: Woodhead Publishing Limited, 2008, pp. 357-373.
17.
Lee KH, Baek DH, Ki CS and Park YHPreparation and characterization of wet spun silk fibroin/poly(vinyl alcohol) blend filaments. Int J Biol Macromol2007; 41: 168-172.
18.
Um IC, Ki CS, Kweon H., Lee KG, Ihm DW and Park YHWet spinning of silk polymer: II. Effect of drawing on the structural characteristics and properties of filament. Int J Biol Macromol2004; 34: 107-119.
19.
Yao J., Masuda H., Zhao C. and Asakura T.Artificial spinning and characterization of silk fiber from Bombyx mori silk fibroin in hexafluoroacetone hydrate. Macromolecules2002; 35: 6-9.
20.
Denkbas, EB , Seyyal, M., Piskin , E. (2000). Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning , J Membr Sci, 172: 33-38.
21.
Gao H., Gu Y. and Ping Q.The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension. J Control Release2007; 118: 325-332.
22.
Williamson MR and Coombes AGGravity spinning of polycaprolactone fibers for applications in tissue engineering. Biomaterials2004; 25: 459-465.
23.
Puppi D., Piras AM, Chiellini F., Chiellini E., Martins A., Leonor IB, et al. Optimized electro-and wet-spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite . J Tissue Eng Regn Med2011; 5: 253-263.
24.
Zhang X., Hua H., Shen X. and Yang Q. In vitro degradation and biocompatibility of poly(l-lactic acid)/chitosan fiber composites. Polymer2007; 48: 1005-1011.
25.
Buranapanitkit B., Srinilta V., Ingviga N., Oungbho K., Geater A. and Ovatlarnporn C.The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system . Clin Orthop Relat Res2004; 424: 244-252.
26.
Makinen TJ, Veiranto M., Lankinen P., Moritz N., Jalava J., Törmälä P., et al. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother2005; 56: 1063-1068.
27.
Ambrose CG, Clyburn TA, Louden K., Joseph J., Wright J., Gulati P., et al. Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clin Orthop Relat Res2004 ; 421: 293-299.
28.
Baro M., Sánchez E., Delgado A., Perera A. and Évora C. In vitro-in vivo characterization of gentamicin bone implants. J Control Release2002; 83: 353-364.
29.
Castro C., Sánchez E., Delgado A., Soriano I., Núñez P., Baro M., et al. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J Control Release2003; 93: 341-354.
30.
Koort JK, Makinen TJ, Suokas E., Veiranto M., Jalava J., Knuuti J., et al. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother2005; 49: 1502-1508.
31.
Rubinstein E.History of quinolones and their side effects . Chemotherapy2001; 47: 3-8.
32.
Drilica K. and Hooper DCMechanisms of Quinolone action. In: Hooper DC and Rubinstein E. (eds). Quinolone antimicrobial agents, 3rd ed. Washington, DC: American Society of Microbiology Press , 2003, pp. 19-40.
33.
Greenberg RN , Newman MT, Shariaty S. and Pectol RWCiprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis . Antimicrob Agents Chemother2000; 44: 164-166.
34.
Darley ESR and MacGowan APAntibiotic treatment of Gram-positive bone and joint infections. J Antimicrob Chemother2004; 53: 928-935.
35.
de Lucas JJ , San Andrés MI, González F., Froyman R. and Rodríguez C.Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle. Vet Res Commun2008; 32: 275-279.
36.
Meinen JB, McClure JT and Rosin E.Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. Am J Vet Res1995; 56: 1219-1224.
37.
Lautzenhiser SJ, Fialkowski JP, Bjorling D. and Rosin E. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs. Res Vet Sci2001 ; 70: 239-241.
38.
Croom KF and Goa KLLevofloxacin: A review of its use in the treatment of bacterial infections in the United States. Drugs2003; 63: 2769-2802.
39.
Lazzarini L. , Mader JT and Calhoun JHOsteomyelitis in long bones. J Bone Jt Surg Am2004; 86: 2305-2318.
40.
McKee MG , Unal S., Wilkes GL and Long TEBranched polyesters: Recent advances in synthesis and performance. Prog Polym Sci2005; 30: 507-539.
McKee MG , Wilkes GL, Colby RH and Long TECorrelations of solution rheology with electrospun fiber formation of linear and branched polyesters. Macromolecules2004; 37: 1760-1767.
43.
Celik A., Kemikli N., Ozturk R., Muftuoglu AE and Yilmaz F.Synthesis, characterization and thermal properties of a novel star polymer consisting of poly([epsilon]-caprolactone) arms emanating from an octa-functional porphyrazine core. React Funct Polym2009; 69: 705-713.
44.
Balakrishnan S., Krishnan M., Dubois P. and Narayan R.Kinetic and thermodynamic considerations in the synthesis of a new three-arm poly(∈-caprolactone) . Polym Eng Sci2004; 44: 1491-1497.
45.
Balakrishnan S., Krishnan M., Dubois P. and Narayan R.Three-arm poly (∈-caprolactone) by extrusion polymerization. Polym Eng Sci2006; 46: 235-240.
46.
Puppi D., Detta N., Piras AM, Chiellini F., Clarke DA, Reilly GC, et al. Development of electrospun three-arm star poly(∈-caprolactone) meshes for tissue engineering application. Macromol Biosci2010; 10: 887-897.
47.
Tsay CS and Mchugh AJMass transfer modeling of asymmetric membrane formation by phase inversion . J Polym Sci Pol Phys1990; 28: 1327-1365.
48.
Tsay CS and McHugh AJA rationale for structure formation during phase inversion. J Polym Sci Pol Phys1992; 30: 309-313.
49.
Wienk IM, Boom RM, Beerlage MAM, Bulte AMW, Smolders CA and Strathmann H.Recent advances in the formation of phase inversion membranes made from amorphous or semi-crystalline polymers. J Memb Sci1996 ; 113: 361-371.
50.
Barton BF, Reeve JL and McHugh AJObservations on the dynamics of nonsolvent-induced phase inversion . J Polym Sci Pol Phys1997; 35: 569-585.
51.
Strathmann H., Kock K., Amar P. and Baker R.The formation mechanism of asymmetric membranes . Desalination1975; 16: 179-203.
52.
Reuvers, AJ , Smolders, CA (1987). Formation of membranes by means of immersion precipitation: Part II. The mechanism of formation of membranes prepared from the system cellulose acetate-acetone-water , J Membr Sci, 34: 67-86.
53.
Mulder M.Influence of various parameters on membrane morphology. In: Mulder M. (ed) Basic principle of membrane technology. Dordrecht, The Netherlands: Kluwer Academic, 1996, pp. 123-140.
54.
Kim JH and Lee KHEffect of PEG additive on membrane formation by phase inversion. J Memb Sci1998; 138: 153-163.
55.
Crow BB, Borneman AF, Hawkins DL, Smith GM and Nelson KDEvaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,Llactide-co-glycolide) fibers . Tissue Eng2005; 11: 1077-1084.
56.
Chang HI, Lau YC, Yan C. and Coombes AGControlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers. J Biomed Mater Res A2008; 84: 230-237.
57.
Crow BB and Nelson KDRelease of bovine serum albumin from a hydrogel-cored biodegradable polymer fiber. Biopolymers2006; 81: 419-427.
58.
Huang X. and Brazel CSOn the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release2001 ; 73: 121-136.
59.
Holtom PD, Pavkovic SA, Bravos PD, Patzakis MJ, Shepherd LE and Frenkel B.Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res2000; 18: 721-727.
60.
Huddleston PM, Steckelberg JM, Hanssen AD, Rouse MS, Bolander ME and Patel R.Ciprofloxacin inhibition of experimental fracture-healing . J Bone Jt Surg Am2000; 82: 161-173.
61.
Perry AC, Prpa B., Rouse MS, Piper KE, Hanssen AD, Steckelberg JM, et al. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing . Clin Orthop Relat Res2003; 414: 95-100.
